58 research outputs found
A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events
Treatment recommendations for the use of bone-targeted agents in 2011— report from the 6th Annual Bone and the Oncologist New Updates meeting
Safety of bevacizumab when given perioperatively for colorectal cancer with liver metastases: McGill University pilot study
Perioperative chemotherapy with bevacizumab (BV) for liver metastases (LM) in colorectal cancer (CRC): McGill University pilot study
- …